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LarynxAbstract Introduction: Amyloidosis is related to the extracellular deposition in various tissues of
an amorphous amyloid substance. Isolated laryngeal localization is very rare.
Observation: We report a case of localized laryngeal amyloidosis discovered during an isolated
chronic dysphonia in a 45-year-old man, with no medical history, with no alcohol or tobacco intox-
ication. The histological and immunohistochemical study and further examinations conﬁrmed the
diagnosis of localized laryngeal amyloidosis without systemic location. The patient had a slight
postoperative hoarseness that subsequently disappeared through speech therapy.
Discussion: The larynx remains a rare localization of amyloidosis. It is the most common form of
amyloidosis of the upper aero digestive tract. Circumstances of discovery of laryngeal amyloidosis
are dominated by hoarseness. Laryngoscopy may falsely suggest a neoplastic disease. Diagnosis is
based upon histological examination with Congo red staining where amyloid deposits appear bire-
fringent under polarized light. Surgery is the mainstay of treatment of symptomatic laryngeal amy-
loidosis. The survival of patients with laryngeal amyloidosis often exceeds ten years.
Conclusion: Laryngeal amyloidosis is essentially a local clinical form whose main symptom is
dysphonia. The treatment is usually based on local endoscopic procedures but may require a laryn-
gectomy in advanced forms, associated with colchicine. The prognosis is much better than systemic
forms.
ª 2014 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Amyloidosis is related to the extracellular deposition in vari-
ous tissues of an amorphous amyloid substance, formed from
different protein precursors. The distribution of the deposits
can be localized or systemic.1 Isolated laryngeal localization
is very rare.2,3 We report a case of localized laryngeal amyloi-
dosis with chronic dysphonia.ed.
Figure 2 Amorphous deposits, PAS positive (40·).
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We report the case of a 45-year-old man, with no medical his-
tory, with no alcohol or tobacco intoxication, hospitalized for
assessment of chronic dysphonia, which appeared two months
before without dysphagia or dyspnea. Endoscopy showed a
nodule of the left vocal cord (Fig. 1), with inﬂammatory aspect
without reduction of laryngeal mobility. A laryngoscopical
microsurgical resection of the polyp was carried out. Histolog-
ical study showed the existence of an amorphous eosinophilic
material stained with Congo red and with a dichroic appear-
ance and a characteristic yellow-green in polarized light. The
immunohistochemical typing was compatible with amyloidosis
(Fig. 2). General clinical examination was normal. The electro-
cardiomyogram and echocardiogram were normal. Renal func-
tion tests showed no proteinuria or pathological urine
sediment, creatinine was normal. There was no cytolysis, chole-
stasis, ionic disorder or inﬂammation. The patient underwent a
gastroscopy and colonoscopy with biopsies (esophagus, stom-
ach, duodenum, colon, rectum) and pathology showed no
abnormalities. Histology of accessory salivary glands biopsy
was normal.
We concluded the diagnosis of a localized laryngeal amyloi-
dosis without systemic location. The patient had a slight postop-
erative hoarseness that subsequently disappeared through
speech therapy. Regular biological controls seeking for evidence
for a systemic form is still negative after a year of follow up.
3. Discussion
The larynx remains a rare localization of amyloidosis, it repre-
sents about 0.17–1.2% of benign laryngeal tumors.4 The ﬁrst
case of laryngeal amyloidosis has been reported by Burow
and Neumann in 1875.5 It may appear at any age, especially
between 40 and 60 years with a slight male predominance (sex
ratio 1.2).3 Isolated laryngeal amyloidosis is the most common
form of amyloidosis of the upper aero digestive tract (nasal cav-
ity, mouth, sinuses, nasopharynx, tongue, pharynx).4,6 The
cause of this preferential laryngeal localization remains poorly
understood. The laryngeal involvement is usually isolated, but
sometimes it can be associated with locations in anatomical
sites near the larynx (nasopharynx, tonsils, nasal cavity or tra-
chea).4 Lower localization including lung have also been
described.6 Circumstances of discovery of laryngeal amyloido-Figure 1 Nasoﬁbroscopy showing polyp in right vocal cord.sis are dominated by hoarseness and dysphonia.6 Sometimes
patients present with dyspnea, stridor, persistent dry cough,
sleeping apnea syndrome or dysphagia (3.6) laryngoscopy
may falsely suggest a neoplastic disease, ﬁbroma, papilloma
or tuberculosis. Furthermore, endoscopic aspects can be very
different, nodular form as in our patient or diffuse inﬁltration
with greater or lesser extent, mainly supraglottic.3 Diagnosis
is based upon histological examination with Congo red staining
where amyloid deposits appear birefringent under polarized
light. In a second step, amyloidosis is characterized by immu-
nohistochemistry using antibodies anti light chains kappa or
lambda and anti-protein A. Some authors completed their
study by anti-b2-microglobulin antibody and anti-prealbumin
anti-antibodies (3.6). In the series of Lewis et al. comprising
11 cases of laryngeal amylosis, 50% of deposits were positive
for anti-light chain lambda, 25% for the anti-light chain kappa
and 25% showed an identical ﬁxing of the two chains, whereas
anti-protein markings A, b2-microglobulin and prealbumin
were negative.6 The frequency of distribution of kappa and
lambda light chains in the laryngeal amyloidosis is identical
to that of systemic AL amyloidosis reported in the literature.3
Searching monoclonal gammopathy has not been systemati-
cally carried out in all cases in the literature, but the biological
explorations including serum protein electrophoresis and
research of urinary light chains were usually normal or nega-
tive, as in our observation. One case of plasmacytoma of the
larynx associated with a contiguous amyloidosis has been
reported.3 Laryngeal amyloidosis is rarely isolated. In this case,
a possible extension or evolution to systemic dissemination
seems very uncommon.6 Surgery is the mainstay of treatment
of symptomatic laryngeal amyloidosis, based on endoscopic
surgery primarily by CO2 laser. When the lesions are exclusively
above glottal, some authors have proposed a partial laryngec-
tomy, more or less extensive, using preoperative CT reconstruc-
tions to guide the surgery.3 Medical treatment involves
colchicine; it is often complementary to surgery.2 It is rare that
endoscopic treatments result in complete destruction of the
lesions avoiding recurrence. This difﬁculty of complete resec-
tion of all amyloid lesions is mainly due to the difﬁcult accessi-
bility of the subglottic region to endoscopic treatments.
Recurrences usually occur within ﬁve years after treatment,
but sometimes very late.3 Finally, in rare reports, a tracheot-
omy was necessary.3,6 The survival of patients with laryngeal
amyloidosis often exceeds ten years; it seems to be much better
than in patients with systemic AL amyloidosis. Rare deaths
Laryngeal amyloidosis 265from the disease are associated with pulmonary involvement or
bleeding during a surgical treatment when the diagnosis of tra-
cheal amyloidosis was not known.2,3,7
4. Conclusion
The laryngeal amyloidosis is essentially a local clinical form
whose main symptom is dysphonia. The treatment is usually
based on local endoscopic procedures but may require a laryn-
gectomy in advanced forms, associated with colchicine. The
prognosis is much better than systemic AL forms.
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